Beyond the enhanced shine, the treatment rinse infuses hair with weightless moisture with a slew of hydrating botanicals—like watermelon oil, lychee, and edelweiss flower. These ingredients also work ...

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

People can't get over just how good she looks after surgery despite undergoing a handful of operations in one sitting ...

Toronto Maple Leafs defenseman Jake McCabe is learning to live with a few busted teeth. The 31-year-old took Lucas Raymond's stick to the face during Toronto's matchup on Dec. 27 against the Detroit ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

At the time of Gunnar's diagnosis, CF patients typically died before reaching ... Gunnar said that after the game, he and his dad shared a moment, knowing that Trikafta was really working and ...

The FDA on Fri­day is­sued two si­mul­ta­ne­ous cys­tic fi­bro­sis ap­provals for Ver­tex Phar­ma­ceu­ti­cals but in­clud­ed high-lev­el safe­ty warn­ings for both.

“In Phase 3 clinical trials, across a broad range of genotypes, once-daily ALYFTREK demonstrated non-inferiority to TRIKAFTA in ppFEV 1 response ... Closer monitoring is advised after resuming ...

Separately, the FDA expanded the indication for Vertex's Trikafta on Friday to include cystic fibrosis patients with additional genetic variants. The FDA initially approved Trikafta in 2019 for ...

and lower sweat chloride levels than Trikafta, is another step in achieving this goal,” he added. Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates ...

Different genetic mutations cause different problems with this particular protein -- so CFTR modulators generally don't work on every CF case. But Vertex's newest blockbuster, Trikafta -- approved in ...